Treatment of Negative Symptoms and Schizophrenia

Phase 2CompletedNCT02204787

University Hospital, Montpellier60 enrolled

Overview

The aim of this study is to evaluate the therapeutic efficacy of a neuromodulation technique, tDCS (transcranial direct current stimulation) used as a complementary treatment on negative symptoms. 60 patients will be randomized into two groups (active tDCS vs sham tDCS) and will be assessed after the intervention, 1 and 3 months after.Secondary outcomes shall include neuropsychological assessment, general symptomatology, extrapyramidal symptoms and social functioning.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Schizophrenia

Interventions

transcranial direct current stimulationDEVICE

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

* Inclusion Criteria: * Schizophrenia with prominent negative symptoms * Exclusion Criteria: * other psychiatric or neurological diseases * specific tDCS limitations

Locations (1)

UH Montpellier

Montpellier, France

Outcomes

Primary Outcomes

Scale for the Assessment of Negative Symptoms

Time frame: up to 3 months after intervention

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.